Corrigan Mark's Form 4 filing
Wave Life Sciences, Inc. (WVE) · filed Dec 10, 2025
- Accession no.
- 0001193125-25-314735
- Filed
- Dec 10, 2025
- Trade date
- Dec 8, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $217.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Corrigan MarkCIK 0001250661 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | Ordinary Shares | SSaleDisposed | −9,600 | $13.09 | −$125,664 | 35,330 | Direct | |
| Dec 8, 2025 | Ordinary Shares | SSaleDisposed | −6,515 | $14.07 | −$91,666.05 | 28,815 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.